Long‐Term Efficacy and Safety of Triple‐Combination Therapy With Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide for Hypertension

J Clin Hypertens (Greenwich). 2012;14:149–157. ©2012 Wiley Periodicals, Inc. Most patients with hypertension require combination therapy in order to achieve blood pressure (BP) goals. This 40‐week open‐label extension of the 12‐week double‐blind Triple Therapy With Olmesartan Medoxomil, Amlodipine,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Hypertens (Greenwich)
Autors principals: Kereiakes, Dean J., Chrysant, Steven G., Izzo, Joseph L., Littlejohn, Thomas, Oparil, Suzanne, Melino, Michael, Lee, James, Fernandez, Victor, Heyrman, Reinilde
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2012
Matèries:
Original Papers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8108825/
https://ncbi.nlm.nih.gov/pubmed/22372774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1751-7176.2011.00588.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars